Sofia, Bulgaria, June 5, 2023 - Pursuant to the requirements of Article 100t of the Securities Act, Sopharma AD announces that at its meeting the Board of Directors of the Company resolved to increase the capital on the condition that the shares from the increase are subscribed by the warrant holders, based on a resolution legally adopted at the General Meeting of Warrantholders (GMW) on June 2, 2023. This notification is not a notification pursuant to art. 89t of the Law on Public Offering of Securities.